ABVC BioPharma
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
-0.632.23
Price/Sales ratio
N/AN/A
Earnings per Share (EPS)
$-4.6$1.3

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-9.33K-3.87K-86.06-12.17-101.88-19.44-9.49-7.05-1.21-0.47-1.05-101.88
Price/Sales ratio
N/A37.22K12.12M19.22K60.07K108.97208.15238.7020.4032.9959.83108.97
Price/Book Value ratio
21.384.30K3.21K37.16-72.67-506.5329.249.606.380.596.62-72.67
Price/Cash Flow ratio
559.5037.22K-111.65-36.49-663.05-24.39-22.03-11.17-2.67-1.18-2.28-663.05
Price/Free Cash Flow ratio
559.5037.22K-111.65-36.49-663.05-24.39-22.03-11.15-2.63-1.18-2.25-663.05
Price/Earnings Growth ratio
93.38N/A-0.08-0.021.150.53-0.060.66-0.160.000.590.53
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/A84.49%N/A29.63%-2563.59%97.13%96.12%98.57%70.46%-98.14%93.05%-2563.59%
Operating Profit Margin
N/A-960.74%-14054046.87%-62317.45%-20034.73%-492.90%-1760.86%-3188.63%-1558.53%-5390.34%-5372.82%-20034.73%
Pretax Profit Margin
N/A-960.74%-14084259.37%-219972.34%-58934.05%-571.49%-2238.70%-3150.90%-1599.80%-6989.62%-5208.98%-58934.05%
Net Profit Margin
N/A-960.74%-14086871.87%-157955.91%-58960.65%-560.51%-2193.08%-3382.78%-1682.06%-6898.67%-5682.73%-58960.65%
Effective Tax Rate
N/A5866.03%-0.01%5.12%-0.04%1.92%2.03%-7.35%-5.14%-2.40%-4.73%1.92%
Return on Assets
-0.10%-47.31%-2541.72%-76.43%-4260.07%-56.77%-91.27%-87.86%-165.51%-72.55%-197.77%-4260.07%
Return On Equity
-0.22%-111.01%-3730.94%-305.32%71.33%2605.41%-308.10%-136.09%-526.44%-125.36%-302.44%2605.41%
Return on Capital Employed
-0.22%-111.01%-3720.40%-79.16%25.46%-3044.21%-125.78%-113.38%-374.49%-95.98%-456.61%-3044.21%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.51N/A
Quick Ratio
-0.020.083.070.130.010.191.442.590.280.270.040.01
Cash ratio
N/A0.083.070.060.000.020.881.570.010.010.010.00
Days of Sales Outstanding
N/AN/AN/AN/A768.14333.17755.171.75K515.431.81K104.63333.17
Days of Inventory outstanding
N/A191.95N/A32.41K2.59-8.64K-16.37K1.86K1.66KN/AN/A-8.64K
Operating Cycle
N/A191.95N/A32.41K770.74-8.31K-15.62K3.62K2.18K1.81K25.79-8.31K
Days of Payables Outstanding
N/AN/A209.53KN/AN/A434.92449.40N/AN/AN/AN/A434.92
Cash Conversion Cycle
N/A191.95-209.53K32.41K770.74-8.74K-16.06K3.62K2.18K1.81K104.63-8.74K
Debt Ratios
Debt Ratio
0.100.68N/A0.168.300.580.400.110.190.100.670.67
Debt Equity Ratio
0.221.60N/A0.67-0.13-26.751.360.180.610.172.13-0.13
Long-term Debt to Capitalization
N/AN/AN/AN/A-0.04N/A0.43N/AN/AN/A0.20-0.04
Total Debt to Capitalization
0.180.61N/A0.40-0.161.030.570.150.370.140.49-0.16
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-136.36N/A
Cash Flow to Debt Ratio
0.160.07N/A-1.51-0.78-0.77-0.96-4.63-3.90-2.88-2.94-0.77
Company Equity Multiplier
2.112.341.463.99-0.01-45.893.371.543.181.723.18-0.01
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A1-108.58K-526.75-90.59-4.46-9.44-21.35-7.62-27.78-26.22-90.59
Free Cash Flow / Operating Cash Flow Ratio
11111111.001.011.001.011
Cash Flow Coverage Ratio
0.160.07N/A-1.51-0.78-0.77-0.96-4.63-3.90-2.88-2.94-0.77
Short Term Coverage Ratio
0.160.07N/A-1.51-1.14-0.77-2.18-4.63-3.90-2.88-3.97-0.77
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A